Norplant

Quick links to important sections

Norplant

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norplant

The Norplant System is a long-acting reversible contraceptive (LARC), classified pharmacologically as a Progestogen-only Contraceptive (POC), designed for long-term pregnancy prevention. The system provides a highly effective, non-daily method of family planning through the continuous release of a synthetic hormone.

Property Description
Active Ingredient Levonorgestrel
Form Subdermal Implant (Six flexible capsules)
Pharmacological Class Progestogen-only Contraceptive (POC)
Common Use Long-term Contraception (Pregnancy Prevention)
Origin Synthetic Hormone

Defining Norplant: Identity and Pharmacological Class

Norplant is a single-ingredient medicinal entity whose primary function is to provide highly consistent contraception over an extended period. It belongs to the progestogen-only contraceptive (POC) class because it contains only the synthetic hormone levonorgestrel and is entirely estrogen-free. This characteristic is clinically recognized as beneficial for female patients who may have medical reasons to avoid estrogen-containing formulations. This progestogen-only delivery method is recognized for its high effectiveness and convenience.

Composition and Drug Form: The Levonorgestrel Implant

The active component in Norplant is levonorgestrel, a potent synthetic progestational hormone. The medicine is supplied as a unique dosage form: a subdermal implant consisting of six thin, flexible silicone capsules. This specific six-capsule design is a distinguishing feature of the original Norplant System. These capsules function as a sustained-release system that gradually and continuously diffuses the hormone directly into the bloodstream over the intended period of use. Levonorgestrel is considered an essential medicine for contraception due to its crucial role in reproductive health.

Key Distinctions in Contraceptive Design

The defining feature of the Norplant System is its design for long-term, reversible use, which removes the need for daily compliance or frequent user intervention. Its non-oral, implanted route of administration delivers the hormone constantly, ensuring consistent levels necessary for reliable pregnancy prevention through ovulation inhibition and changes to the cervical mucus. This makes it a favored choice for female patients seeking minimal-maintenance contraception.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Norplant?

Possible Side Effects and Safety Information

The safety profile of the Norplant System (levonorgestrel implants) is predominantly characterized by effects on the reproductive system and general systemic changes, as documented in regulatory sources.

Frequency-Classified Adverse Reactions

The most frequent safety concern involves menstrual irregularities, which are classified as Very Common (affecting ge 10% of users). These include irregular bleeding, spotting, prolonged bleeding, or, conversely, amenorrhea (absence of periods). Other common (%1 to 10%) systemic effects include headache, nervousness, dizziness, breast tenderness, and weight change (increase or decrease).

System-Organ Class Common Adverse Reactions
Reproductive System Vaginitis, Leukorrhea, Pelvic Pain
Skin/Subcutaneous Acne, Alopecia (hair loss)
General Disorders Local pain or reactions at the implant site

Serious Safety Considerations

Official labeling addresses rare but significant safety risks. Like other hormonal contraceptives, the system is associated with a risk of thromboembolic events (blood clots), including deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. If pregnancy occurs while using the implant, there is an increased likelihood of it being an ectopic pregnancy.

Regulatory Safety Restrictions

The system is contraindicated (should not be used) in patients with specific pre-existing medical conditions. These restrictions include known or suspected carcinoma of the breast, undiagnosed abnormal genital bleeding, active thromboembolic disorders, and markedly impaired liver function or liver tumors. The official safety data notes that menstrual irregularities are most pronounced during the initial six to twelve months of use and may decrease thereafter.

Overdose and Emergency Response

The official regulatory documents define the overdose profile for the Norplant System, which provides continuous release of the progestogen levonorgestrel via subdermal implants. Overdose is related to exposure to excessive levels of the hormone, typically resulting from the presence of an excessive number of implants.

Documented Overdose Manifestations

Manifestations of overdose are officially documented to include clinical signs associated with progestogen excess. These are primarily nausea and vomiting—affecting the gastrointestinal system—and vaginal bleeding, which is recognized as a form of withdrawal bleeding. Severe or life-threatening outcomes specific to the Norplant overdose are not uniquely documented in the official regulatory sections beyond these expected signs of hormone excess.

Emergency Actions and Required Management

In the event of a suspected overdose, the primary official guidance is to seek immediate medical attention. The essential, mandated action required to stop the continuous exposure to the active ingredient is the procedural removal of the implants. This intervention directly addresses the source of the overdose.

Following implant removal, management is restricted to symptomatic and supportive treatment to address any resulting clinical manifestations. The official prescribing information explicitly states that no specific antidote is known for a levonorgestrel overdose. Hospital monitoring may be required for observation and management of any symptoms that persist after the hormone source is removed.

Therapeutic Uses of Norplant

What Norplant Treats: Main Uses and Benefits

The Norplant System, utilizing the active ingredient levonorgestrel, is relevant across therapeutic domains where long-term support for pregnancy prevention is sought. The use of the levonorgestrel-releasing system is applied in contexts involving long-term contraception for women of reproductive age.


Long-Term, Highly Reliable Contraceptive Protection

This domain is applied in clinical settings that involve the need for sustained, continuous family planning where the prevention of pregnancy is the primary goal. The system is commonly used to help with long-term pregnancy prevention. It is relevant for managing symptoms that interfere with daily comfort, such as the anxiety and stress associated with the potential for inconsistent use of other methods. It assists with maintaining functional stability by providing supportive management of reproductive health.

Essential Estrogen-Free Contraceptive Alternative

This therapeutic benefit is relevant in clinical settings marked by the requirement to avoid estrogen-containing formulations. The Norplant System is a progestogen-only contraceptive that can be applied across domains where other methods are medically unsuitable, providing supportive relief by offering a safe avenue for family planning.

Minimizing the Burden of Daily Compliance

This system is commonly used to help with continuous support for long-term family planning, addressing the need for sustained continuous management and simplified contraceptive adherence.


Quick Fact: Relief for Compliance Burden

The system assists with managing symptoms related to maintaining adherence to frequent schedules, supporting relief from the strain of daily compliance.

Regulatory References

  1. WHO Essential Medicines List for Levonorgestrel

Eligibility and Restrictions for Use

The Norplant System is an officially approved contraceptive method for women of reproductive age. Eligibility is strictly defined by regulatory criteria, with absolute restrictions imposed for specific health conditions. The system is not indicated for use before menarche or in post-menopausal women.

Contraindications (Must Not Use)

Official regulatory documents prohibit the use of levonorgestrel implants in patients who have:

  • Known or suspected pregnancy.
  • Active thromboembolic disorders (e.g., blood clots).
  • Acute liver disease or benign/malignant liver tumors.
  • Known or suspected breast cancer or other progestin-sensitive cancer.
  • Undiagnosed abnormal genital bleeding.

Conditional Use and Restrictions

Some populations require special consideration or have documented limitations:

  • Markedly impaired liver function or liver disease is a condition for which use is not recommended.
  • Women whose body weight exceeds 60 kg or 132 lbs may experience a reduction in the duration of contraceptive efficacy.
  • During lactation, use is generally permissible, but specific regulatory guidance may advise against insertion in the immediate postpartum period.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The primary concern regarding Norplant (levonorgestrel implants) interactions is the potential for other substances to reduce the concentration of levonorgestrel in the bloodstream, which may lead to a loss of contraceptive protection and risk of unintended pregnancy. These clinically significant interactions are generally driven by the induction of liver enzymes, specifically the CYP3A4 system, which accelerates the metabolism of the active hormone.


Clinically Significant Interactions (Reduced Efficacy Risk)

Official regulatory information identifies specific drug classes and products that compromise Norplant's effectiveness through enzyme induction. Patients using these substances should be advised to consider non-hormonal or alternative contraceptive methods.

Substance Category Examples (Explicitly Listed) Interaction Mechanism
Anticonvulsants Phenytoin, Carbamazepine Hepatic Enzyme Induction
Anti-tuberculosis Drugs Rifampin Hepatic Enzyme Induction
HIV/AIDS Medications Efavirenz Enzyme Induction
Herbal Supplements St. John's Wort CYP3A4 Enzyme Induction

Other Interaction Considerations

Due to the continuous, sustained release nature of the subdermal implant, there are typically no specific regulatory constraints regarding the timing of Norplant administration relative to food or other medications.

No drug combinations are consistently listed as absolutely contraindicated in the interaction sections of regulatory labels, though severe hepatic disease is a general contraindication for use.

Mechanism of Action

The mechanism of Norplant's active ingredient, levonorgestrel, is based on its continuous action as a synthetic progestin, a Progesterone Receptor ( PR) agonist, initiating a three-tiered physiological change to disrupt the reproductive cascade.

Central Suppression of the Ovulation Cascade

The primary mechanistic domain involves levonorgestrel activating PRs in the hypothalamus and pituitary gland, initiating a negative feedback loop on the Hypothalamic-Pituitary-Ovarian ( HPO) Axis. This action suppresses the release of Luteinizing Hormone ( LH), which regulates the final stage of folliculogenesis. The physiological consequence of this central signaling blockade is anovulation.

Peripheral Barrier Mechanism

The secondary domain involves the drug's localized effect on the reproductive tract tissues. Levonorgestrel acts on PRs in the cervix to cause a dramatic increase in the thickness and viscosity of the cervical mucus, while also modulating the endometrium (uterine lining) to induce an atrophic state. These parallel peripheral actions result in a dense physical barrier that alters sperm motility and modifies endometrial receptivity.

Dosage and Administration Information

How to Use Norplant

The Norplant System is utilized as a procedure-based, long-acting method, following established administration guidelines. The system is defined by its subdermal route and continuous, non-daily dosing pattern.

Administration Scope

Feature Description
Route of Administration Subdermal insertion in the medial aspect of the upper arm.
Dosing Schedule Continuous release from 216 mg total levonorgestrel; the daily release rate starts at approximately 85 mug and gradually declines over time.
Special Procedural Conditions Insertion requires a healthcare professional trained in the specific technique and is typically scheduled during the first seven days of the onset of menses.
Maximum Use Duration Provides continuous hormone delivery for up to 5 years, after which removal or replacement is required to maintain efficacy.

Contextual Use Classifications

Feature Classification
Administration Method Type Implantation (Subdermal).
Frequency Pattern Single application followed by continuous release.
Use-Context Constraints Procedure-based (requires specialist); concentrations vary inversely with body weight.

Connection to the Overall Use Protocol

The protocol establishes the use of the Norplant System as a long-term course defined by a single surgical application and a 5-year maximum duration. This requirement emphasizes that a trained professional is necessary for both the initial insertion and the final removal, fundamentally separating the use of this system from self-administered methods. The dosing is determined by the fixed, continuous release pattern of the implanted capsules, rather than by frequent user action.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Norplant

Evidence for Use in Long-term Contraception (Pregnancy Prevention)

The system was studied for continuous pregnancy prevention using Randomized Controlled Trials (RCTs) and large observational cohorts. Studies monitored the rate of unintended pregnancy and user continuation rates. Findings describe patterns observed where rates of unintended pregnancy were low across observed populations. The comparative evidence is lacking for direct head-to-head trials against all short-acting methods like the pill.

Evidence for Use as an Estrogen-Free Contraceptive Alternative

Research was evaluated in women requiring a progestogen-only method. Pharmacokinetic research examined whether the system delivers a continuous, stable level of levonorgestrel and describes its estrogen-free composition. Studies monitored metabolic markers, which appears to differ from patterns observed with combined hormonal methods. However, the body of observational research for women with highly specific medical reasons to avoid estrogen remains limited.

Long-term Studies and Subgroup Uncertainty

Clinical protocols observed patients over follow-up durations that were limited to five to seven years, showing continuous hormone release over that period. Research explored outcomes in specific subgroups, including women categorized by higher body weight (e.g., over 70 kg or 154 lbs) and those categorized by prior pregnancy history (parity). Findings in the higher body weight group were mixed, and data for certain groups remain insufficient regarding function after the fifth year.

Research Gaps and Areas of Uncertainty

The evidence highlights several areas where the certainty remains low. Comparative evidence is lacking from large-scale RCTs against the most widely used non-implant contraceptive methods. Furthermore, subgroup findings are uncertain when trying to generalize effects, such as the mixed observations on method function in women with higher body weight. This final section synthesizes areas where long-term effects are not fully established and where data for certain groups remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Norplant (FAQ)

Q: Is Norplant still available to be prescribed?

A: The original Norplant system has been discontinued by the manufacturer and is no longer being inserted. Individuals seeking a similar long-acting reversible contraceptive (LARC) method are typically offered newer implants containing the same or a similar hormone.

Q: How quickly does Norplant begin to prevent pregnancy?

A: Regulatory guidance suggests that if the implant is inserted within the first seven days of the menstrual cycle, a backup contraceptive method is not needed. This timing allows a patient to rely on the implant for contraception without needing a backup method, based on clinical guidelines.

Q: What is the difference between Norplant and other hormonal implants?

A: The original Norplant system is distinguished by its composition: it uses six flexible capsules, each containing levonorgestrel. Other newer implants on the market typically use a different number of rods or capsules, which may also contain different synthetic hormones.

Q: Do you gain weight while using Norplant?

A: Official product information lists weight change as a common adverse reaction, which includes both increase and decrease. Specifically, weight gain has been reported as a potential metabolic adverse effect.

Q: Is it common to have irregular bleeding with Norplant?

A: Yes, regulatory documents classify menstrual irregularities as a very common safety concern. These can include prolonged bleeding, amenorrhea (absence of bleeding), spotting, and irregular onset of bleeding.

Q: Can Norplant cause mood swings or depression?

A: Official adverse reaction reports include depression, mood swings, and nervousness. Patients who experience severe mood changes should discuss their symptoms with a healthcare professional.

Q: Is there an increased risk of blood clots with Norplant?

A: The product is contraindicated (should not be used) in patients with active thromboembolic disorders (blood clots). This contraindication is standard for hormonal contraceptives and is noted in the official product information.

Q: Can Norplant be removed earlier than the typical duration?

A: Yes, the system is officially described as a reversible contraceptive system. The implants can be removed by a trained healthcare professional at any time if the patient chooses to discontinue the method.

Q: What is the process for getting Norplant removed?

A: Removal is a minor surgical procedure that must be performed by a trained healthcare professional. It involves using a local anesthetic to numb the area, making a small incision, and using specialized instruments to extract each capsule.

Q: Does the removal of Norplant hurt?

A: A local anesthetic is used during the removal procedure to manage pain. However, official information notes that the removal process may sometimes be more difficult and/or more painful than the initial insertion.

Q: How quickly can a person become pregnant after Norplant is removed?

A: Studies and official information indicate that the contraceptive effect disappears soon after the implants are removed. A rapid return to normal fertility has been observed in women who discontinue the method.

Q: Is Norplant appropriate for people who have never been pregnant?

A: The product is indicated for the prevention of pregnancy in women of reproductive age. Use is not dependent on prior pregnancy history.

Q: Can Norplant be used while breastfeeding?

A: The hormone passes into breast milk. While official guidance may advise against insertion during the immediate postpartum period, insertion may be permitted anytime between childbirth and six months postpartum, provided the monthly bleeding has not returned.

Q: Does Norplant affect future fertility?

A: Official information confirms that the contraceptive effect of the implants is reversible. Studies have observed a rapid return to normal fertility once the implants have been removed.

Q: Can you feel the Norplant implants once they are in place?

A: Yes, the implants are placed in the subdermal layer (just under the skin) of the upper arm. Due to their placement, they can typically be felt by the fingers and sometimes their outlines may be visible beneath the skin.

Q: What should be done if the insertion site becomes bruised or tender?

A: To minimize bruising and aid healing, official post-insertion care generally advises keeping the insertion site clean and dry for at least 48 hours. A pressure bandage may be applied, and post-insertion care typically includes keeping the site clean and dry for a specified period.

Q: Is it possible for Norplant to migrate or move from the insertion site?

A: In literature related to difficult removals, capsule displacement from the original insertion site has been cited. This possibility highlights the importance of the initial proper insertion technique by a trained professional.

Q: Are there any long-term health risks associated with Norplant use?

A: The system was studied for the duration of its use, which is five years. Clinical studies over that period generally concluded the method was well-tolerated, with serious adverse events found to be extremely rare.

Q: How does the hormone in Norplant compare to the hormones in birth control pills?

A: Norplant delivers the same progestin (levonorgestrel) found in some oral contraceptive pills. However, the continuous release mechanism results in lower hormone levels than those typically seen from a daily oral contraceptive.

Q: Does Norplant affect libido or sex drive?

A: Changes in sex drive are documented in official reports of adverse reactions. Specifically, decreased libido has been reported by some users.

Q: Is Norplant mentioned in any major medical studies about long-term contraception?

A: Yes, the effectiveness and safety profile of the system have been studied extensively. Key research includes the WHO's large-scale Postmarketing Surveillance and a seven-year multicenter trial examining efficacy over time.

Q: Can I use Norplant if I have a history of migraines?

A: Migraines are listed as a possible side effect of the implant. Additionally, official prescribing information advises that patients with a history of depression should use caution when considering this method.

Q: Does Norplant have a specific weight limit for use?

A: Official data indicates that efficacy is documented to vary inversely with body weight. Clinical studies observed that pregnancy rates were found to increase with weight, which is a factor to consider in the duration of use.

Q: What happens if Norplant is not removed by the recommended date?

A: Removal or replacement is required by the end of the fifth year to ensure the system’s continued contraceptive efficacy. The product information states that removal or replacement is required by the end of the fifth year to maintain efficacy.

Q: Can other healthcare conditions change how Norplant works?

A: Yes, the prescribing information notes conditions that require caution or prohibit use. For example, liver disease is a contraindication, and caution is advised for patients with conditions like diabetes.

Q: Are there reports of hair loss or change in hair texture with Norplant?

A: Official adverse reaction reports include alopecia (hair loss). Other hair-related effects such as hirsutism (excessive hair growth) and hypertrichosis have also been reported.

Q: Does official information suggest Norplant can cause acne?

A: Yes, acne is listed in the official prescribing information as a common adverse reaction that has been reported by users.

Q: How does the placement procedure for Norplant work?

A: Insertion is a minor surgical procedure performed by a trained healthcare professional. After applying a local anesthetic, a specialized instrument called a trocar is used to place the six capsules subdermally (just under the skin) in the upper arm.

Q: What is the risk of scarring at the Norplant insertion site?

A: Local scar formation at the insertion or removal site is cited in literature as a possible outcome of the procedure.

Q: How is Norplant different from an IUD?

A: The Norplant System is a subdermal implant inserted into the arm, which releases hormones into the bloodstream. An IUD (Intrauterine Device) is a distinct contraceptive device that is inserted directly into the uterus.

Q: Are there any non-hormonal side effects of Norplant?

A: Yes, local effects that are not primarily hormonal include local pain, itching, and the potential for infection or other skin reactions at the insertion site.

Q: Do you need to use a backup birth control method immediately after Norplant insertion?

A: The requirement for a backup method depends on the timing of the procedure relative to the menstrual cycle. If the implants are inserted within the first seven days of menses, a backup method is not needed.

Q: Can vitamins or herbal supplements affect Norplant?

A: The official prescribing information specifically lists the herbal supplement St. John's Wort as a substance that can reduce the efficacy of the implant. This potential interaction may require a discussion with a healthcare provider regarding potential drug interactions.

Q: Does Norplant protect against sexually transmitted infections (STIs)?

A: No, like other hormonal contraceptives, Norplant does not protect against HIV/AIDS or other sexually transmitted infections (STIs).

Q: Is Norplant approved for use in women of all ages?

A: It is indicated for use in women of reproductive age. It is not intended for use before a woman has started her menstrual cycles (pre-menarche) or after menopause.

Q: Is it possible to be allergic to Norplant?

A: Yes, the product is contraindicated in patients with a known hypersensitivity (an allergy) to the active drug, levonorgestrel.

How should Norplant be stored and disposed of?

How to Store and Dispose of Norplant?

The Norplant System is intended for storage and handling by healthcare professionals to ensure product integrity and sterility before insertion.

Official Storage Requirements

The levonorgestrel implants must be stored at controlled room temperature, typically 15 C to 30 C (59 F to 86 F). It is mandatory to store the package away from excess heat and moisture and to keep the implants in their original sterile pouch until the procedure. Use must occur by the expiration date printed on the packaging.

Official Disposal Instructions

All instruments, particularly sharps (such as the trocar), used for insertion or removal, are for single use only and must be immediately disposed of in an appropriate sharps container. Any unused or expired implants, along with contaminated materials, must be discarded according to local pharmaceutical and medical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Norplant found in:

A-Z Index: